Synlogic appoints molly harper as chief business officer

Cambridge, mass., sept. 27, 2021 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of molly harper as chief business officer.
SYBX Ratings Summary
SYBX Quant Ranking